Analyst Ratings for Zentalis Pharmaceuticals (ZNTL)
ZNTL Rating Summary
ZNTL Price Target Summary
- Highest: $5.00 (Wells Fargo)
- Lowest: $2.00 (Leerink Partners)
- Average: $3.67
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$3.67 (+59.4%)
* Over Last 12-Mos
Rating Score: 5 / 10
Percentile Rank: 52%
Rating Score: 5 / 10
Percentile Rank: 52%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/12/2024 | Wedbush | Robert Driscoll | Upgrade | Neutral (Underperform) |
4.00 (N/A) |
3.00 (2.30) |
-23.33% | Details |
| 6/20/2024 | UBS » Updated 1/28/2025 |
Eliana Merle | Downgrade | Neutral (Buy) |
2.20 (5.00) |
4.14 (2.30) |
-44.44% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
